Neurocrine Biosciences shares owned by EFG Asset Management
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by EFG Asset Management
from 13F filings
Historical chart of EFG Asset Management investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by EFG Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by EFG Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $245k | 1.8k | 137.92 |
| 2023-12-31 | $370k | 2.8k | 131.76 |
| 2023-09-30 | $362k | 3.2k | 112.50 |
| 2023-06-30 | $296k | 3.1k | 94.30 |
| 2023-03-31 | $270k | 2.7k | 101.22 |
| 2022-12-31 | $247k | 2.1k | 119.44 |
| 2022-09-30 | $233k | 2.2k | 106.30 |
| 2022-06-30 | $214k | 2.2k | 97.63 |
| 2022-03-31 | $218k | 2.3k | 93.88 |
| 2020-03-31 | $1.8M | 20k | 86.56 |
| 2019-12-31 | $2.2M | 20k | 107.49 |
| 2019-09-30 | $2.2M | 25k | 90.10 |
| 2018-12-31 | $1.6M | 22k | 71.40 |
| 2018-09-30 | $2.4M | 20k | 122.95 |